SCHEMBL4071665

SCHEMBL4071665

CCN(CC)CCN(Cc1cc2cccc(C)c2[nH]c1=O)S(=O)(=O)c1ccc2c(c1)OCCN2C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.57
KDM4E B2RXH2 11/20 0.57
HSD17B10 Q99714 8/20 0.57
MAPK1 P28482 4/20 0.57
LMNA P02545 3/20 0.57
MAPT P10636 2/20 0.57
KMT2A Q03164 4/20 0.49
HTT P42858 1/20 0.45
USP2 O75604 1/20 0.45
MEN1 O00255 2/20 0.44
HPGD P15428 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5446708 0.93 KDM4E (0.59) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL5460816 0.93 KDM4E (0.61) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL5446964 0.92 KDM4E (0.59) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL4069417 0.91 KDM4E (0.58) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL5449313 0.90 KDM4E (0.58) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL4080313 0.89 KDM4E (0.57) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL5463304 0.89 KDM4E (0.57) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL4081440 0.89 KDM4E (0.57) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL4073273 0.89 KDM4E (0.56) ALDH1A1KDM4EHSD17B10MAPK1LMNA
SCHEMBL4079834 0.89 KDM4E (0.56) ALDH1A1KDM4EHSD17B10MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2040711-A2 2-OXO-1,2-DIHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS Amphora Discovery Corporation (US) 2009-04-01 EP claimed
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US claimed
WO-2007136592-A2 2-0X0-L,2-DIHYDR0QUIN0LINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS AMPHORA DISCOVERY CORPORATION (US) 2007-11-29 WO claimed
EP-2040711-A2 2-OXO-1,2-DIHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS Amphora Discovery Corporation (US) 2009-04-01 EP disclosed
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US disclosed
WO-2007136592-A2 2-0X0-L,2-DIHYDR0QUIN0LINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS AMPHORA DISCOVERY CORPORATION (US) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof ABCG2, ATP5ME, ATP5MG ALDH1A1 1055/4885KDM4E 2403/4885HSD17B10 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.